PUBLISHER: Grand View Research | PRODUCT CODE: 1869913
PUBLISHER: Grand View Research | PRODUCT CODE: 1869913
The global livestock health market size was estimated at USD 39.53 billion in 2024 and is projected to reach USD 91.42 billion by 2033, growing at a CAGR of 9.93% from 2025 to 2033. Leading factors driving the market growth are rising disease burden and zoonotic threats, increased sustainability and climate-resilient livestock production, technological advancement in diagnostics and preventive care, growing government support, policy alignment, and global collaboration.
The global market is witnessing robust expansion, primarily influenced by the escalating burden of infectious and zoonotic diseases and the rapid evolution of diagnostic and preventive technologies. These two dynamics are redefining animal health management practices, shaping government policy, and steering investments toward innovative, data-driven, and sustainable livestock care solutions worldwide. The growing incidence of transboundary and zoonotic diseases has become a defining factor in driving the demand for advanced veterinary interventions. Persistent outbreaks of conditions such as avian influenza, foot-and-mouth disease (FMD), African swine fever, and coccidiosis continue to disrupt livestock production systems, posing substantial risks to food security and international trade. In response, both public and private sectors are intensifying efforts to enhance disease surveillance, vaccination coverage, and biosecurity infrastructure.
The U.S. Department of Agriculture's allocation of over USD 800 million to combat H5N1 exemplifies the increasing scale of government intervention to contain animal disease threats. Similar measures are being implemented across Latin America, the Middle East, and Africa, where regional authorities are strengthening early warning systems and veterinary response capabilities. Moreover, the growing emphasis on the One Health framework, linking animal, human, and environmental health, has promoted cross-sector collaboration, developing novel vaccines, diagnostic tools, and antimicrobial alternatives designed to curb both animal and public health risks.
Concurrently, technological advancements in diagnostics and preventive medicine are revolutionizing livestock management. The emergence of molecular diagnostics, AI-driven health monitoring, biosensors, and portable testing devices has enabled earlier detection and more efficient containment of diseases. In Europe, for example, technologies such as Boehringer Ingelheim's SoundTalks respiratory monitoring system and Lely's Zeta calving sensor are transforming on-farm disease management by providing continuous, real-time insights into herd health. Likewise, in the Asia Pacific region, deploying advanced imaging platforms such as Esaote's Magnifico Vet MRI underscores the region's growing investment in precision veterinary diagnostics. Digital platforms now facilitate data integration across farms, laboratories, and regulatory agencies, creating a more coordinated ecosystem for disease tracking and control.
Collectively, the interplay between increasing disease pressure and technological innovation is reshaping the global livestock health landscape. The industry is steadily transitioning from a reactive treatment model to one centered on prevention, precision, and predictive health management. As global demand for animal protein rises and biosecurity concerns intensify, these trends are expected to underpin long-term growth, resilience, and sustainability in the livestock health sector.
Global Livestock Health Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global livestock health market report based on product, animal, distribution channel, end use, and region: